The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies.
作者信息
Ferrandi Peter J, Alway Stephen E, Mohamed Junaith S
机构信息
Laboratory of Muscle and Nerve, Department of Diagnostic and Health Sciences, College of Health Professions, University of Tennessee Health Science Center, Memphis, Tennessee.
Center for Muscle, Metabolism and Neuropathology, Division of Rehabilitation Sciences, College of Health Professions, University of Tennessee Health Science Center, Memphis, Tennessee.
出版信息
J Appl Physiol (1985). 2020 Oct 1;129(4):864-867. doi: 10.1152/japplphysiol.00321.2020. Epub 2020 Jul 16.
Abstract
摘要
相似文献
1
The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与血管紧张素转换酶2（ACE2）之间的相互作用可能会对骨骼肌的病毒易感性和肌病产生影响。
J Appl Physiol (1985). 2020 Oct 1;129(4):864-867. doi: 10.1152/japplphysiol.00321.2020. Epub 2020 Jul 16.
2
Last Word on Viewpoint: The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies.关于观点的最后一点：严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与血管紧张素转换酶2（ACE2）之间的相互作用可能会对骨骼肌的病毒易感性和肌病产生影响。
J Appl Physiol (1985). 2020 Oct 1;129(4):872. doi: 10.1152/japplphysiol.00785.2020.
3
Commentaries on Viewpoint: The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies.观点评论：严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与血管紧张素转换酶2（ACE2）之间的相互作用可能会对骨骼肌的病毒易感性和肌病产生影响。
J Appl Physiol (1985). 2020 Oct 1;129(4):868-871. doi: 10.1152/japplphysiol.00775.2020.
4
Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk.血管紧张素转换酶2（ACE2）受体、哮喘与严重新型冠状病毒肺炎感染风险
Eur Ann Allergy Clin Immunol. 2020 Nov;52(6):282-285. doi: 10.23822/EurAnnACI.1764-1489.169. Epub 2020 Nov 3.
5
Oral submucous fibrosis and COVID-19: Perspective on comorbidity.口腔黏膜下纤维化与新型冠状病毒肺炎：关于合并症的观点
Oral Oncol. 2020 Aug;107:104811. doi: 10.1016/j.oraloncology.2020.104811. Epub 2020 May 21.
6
Is the ACE2 Overexpression a Risk Factor for COVID-19 Infection?ACE2 过表达是否是 COVID-19 感染的危险因素？
Arch Med Res. 2020 May;51(4):345-346. doi: 10.1016/j.arcmed.2020.03.011. Epub 2020 Apr 4.
7
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）在人血管紧张素转换酶2（hACE2）转基因小鼠中的致病性。
Nature. 2020 Jul;583(7818):830-833. doi: 10.1038/s41586-020-2312-y. Epub 2020 May 7.
8
[ACE2 and coronavirus - a question of balance and dynamics?].[血管紧张素转换酶2与冠状病毒——平衡与动态变化的问题？]
Lakartidningen. 2020 Apr 17;117:F3S3.
9
ACE2 mouse models: a toolbox for cardiovascular and pulmonary research.ACE2 小鼠模型：心血管和肺部研究的工具包。
Nat Commun. 2020 Oct 14;11(1):5165. doi: 10.1038/s41467-020-18880-0.
10
Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Parkinsonism: Is There Evidence for Concern?严重急性呼吸综合征冠状病毒2感染与帕金森症：是否有值得关注的证据？
Mov Disord. 2020 Oct;35(10):1725. doi: 10.1002/mds.28247.
引用本文的文献
1
The Assessment of Muscle Strength and Cardiorespiratory Parameters Using Simple Tests in Older Adults With Recovery From Mild COVID-19.在从轻度新冠肺炎康复的老年人中使用简单测试评估肌肉力量和心肺参数
Ann Rehabil Med. 2024 Dec;48(6):389-395. doi: 10.5535/arm.240033. Epub 2024 Dec 10.
2
Distinguishing pain profiles among individuals with long COVID.区分长新冠患者的疼痛特征。
Front Rehabil Sci. 2024 Oct 18;5:1448816. doi: 10.3389/fresc.2024.1448816. eCollection 2024.
3
IGSF1: a biomarker for predicting prognosis, immunotherapy response, and drug candidates in COVID-19 combined hepatocellular carcinoma.IGSF1：一种用于预测COVID-19合并肝细胞癌预后、免疫治疗反应及候选药物的生物标志物。
Discov Oncol. 2024 Oct 29;15(1):599. doi: 10.1007/s12672-024-01483-2.
4
Acute Sarcopenia: Mechanisms and Management.急性肌肉减少症：机制与管理。
Nutrients. 2024 Oct 10;16(20):3428. doi: 10.3390/nu16203428.
5
Musculoskeletal, Pulmonary, and Cardiovascular COVID-19 Sequelae in the Context of Firefighter Occupational Health: A Narrative Review.肌肉骨骼、肺部和心血管 COVID-19 后遗症与消防员职业健康的关系：叙事性综述。
Int J Environ Res Public Health. 2024 Oct 19;21(10):1383. doi: 10.3390/ijerph21101383.
6
Effects of aerobic training on cardiopulmonary fitness in patients with long COVID-19: a randomized controlled trial.有氧运动对长新冠患者心肺功能的影响：一项随机对照试验。
Trials. 2024 Oct 3;25(1):649. doi: 10.1186/s13063-024-08473-3.
7
Advance in the mechanism and clinical research of myalgia in long COVID.新冠后综合征肌痛的机制与临床研究进展
Am J Clin Exp Immunol. 2024 Aug 25;13(4):142-164. doi: 10.62347/TXVO6284. eCollection 2024.
8
Chloroquine: Rapidly withdrawing from first-line treatment of COVID-19.氯喹：迅速退出新冠病毒病一线治疗。
Heliyon. 2024 Aug 28;10(17):e37098. doi: 10.1016/j.heliyon.2024.e37098. eCollection 2024 Sep 15.
9
Impact of the COVID-19 pandemic on risk of sarcopenia: From lockdown and infection perspectives: A systematic review and meta-analysis.COVID-19 大流行对肌少症风险的影响：从封锁和感染角度来看：系统评价和荟萃分析。
Medicine (Baltimore). 2024 Aug 9;103(32):e39257. doi: 10.1097/MD.0000000000039257.
10
Mitochondrial mechanisms in the pathogenesis of chronic inflammatory musculoskeletal disorders.慢性炎症性肌肉骨骼疾病发病机制中的线粒体机制
Cell Biosci. 2024 Jun 8;14(1):76. doi: 10.1186/s13578-024-01259-9.
本文引用的文献
1
Cell entry mechanisms of SARS-CoV-2.SARS-CoV-2 的细胞进入机制。
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727-11734. doi: 10.1073/pnas.2003138117. Epub 2020 May 6.
2
The trinity of COVID-19: immunity, inflammation and intervention.COVID-19 的三位一体：免疫、炎症和干预。
Nat Rev Immunol. 2020 Jun;20(6):363-374. doi: 10.1038/s41577-020-0311-8. Epub 2020 Apr 28.
3
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts.人心脏中假定的新型冠状病毒受体血管紧张素转换酶2的细胞类型特异性表达。
Eur Heart J. 2020 May 14;41(19):1804-1806. doi: 10.1093/eurheartj/ehaa311.
4
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.中国 COVID-19 患者 1590 例的合并症及其影响：一项全国性分析。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.
5
Rhabdomyolysis as Potential Late Complication Associated with COVID-19.横纹肌溶解症作为与 COVID-19 相关的潜在迟发性并发症。
Emerg Infect Dis. 2020 Jul;26(7):1618-1620. doi: 10.3201/eid2607.200445. Epub 2020 Jun 21.
6
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
7
Clinical Characteristics of Imported Cases of Coronavirus Disease 2019 (COVID-19) in Jiangsu Province: A Multicenter Descriptive Study.江苏省输入性新型冠状病毒肺炎（COVID-19）病例的临床特征：一项多中心描述性研究。
Clin Infect Dis. 2020 Jul 28;71(15):706-712. doi: 10.1093/cid/ciaa199.
8
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.SARS-CoV2 的神经侵袭性可能在 COVID-19 患者的呼吸衰竭中起作用。
J Med Virol. 2020 Jun;92(6):552-555. doi: 10.1002/jmv.25728. Epub 2020 Mar 11.
9
Understanding of COVID-19 based on current evidence.基于现有证据对 COVID-19 的理解。
J Med Virol. 2020 Jun;92(6):548-551. doi: 10.1002/jmv.25722. Epub 2020 Mar 5.
10
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
Zotero 插件